About INTA

INTA News

Stay up to date on what’s happening inside the world’s largest network of brand owners and trademark professionals. We bring you exciting event news, important advocacy insights, committee developments, spotlights on members in our tight-knit community, and much more.

Press Releases

INTA Launches New Study Mapping Global Counterfeit Trade Routes

New resource provides data-driven analysis and visual mapping to help stakeholders better understand illicit trade patterns and exposure points across global supply chains.

Press Releases

INTA Releases Think Tank Report Finding AI, Client Pressure, and New Business Models Are Reshaping the Future of IP Law Firms

INTA released its IP Law Firms of the Future Think Tank Report, an updated global study examining how intellectual property law firms operate and compete today and into the future.

INTA in the News

Featured highlights from our media coverage around the world.

Press Releases

Stay informed about our latest policies, initiatives, events, awards, and other Association news.

Interviews

When the Ink Dries: Courtney Laginess from Global Payments on...

Published: February 25, 2026

Courtney Laginess, session moderator at this year’s NYC Conference, explains why M&A success hinges on post-close brand strategy, legacy IP decisions, and navigating today’s deal realities.

More

Features

The Steps to Better Online Protection for Famous and Well-Known Marks

Multiple Authors

Published: February 25, 2026

The trademark community agrees that famous and well-known marks are entitled to protection. However, in the case of online infringement, opinions differ about whether new measures are required or existing ones are enough.

More

Law & Practice

CANADA: Federal Court of Appeal Clarifies Confusion Analysis in the...

Jayme Millar Miller Thomson Waterloo, Canada INTA Bulletins Correspondent

Published: February 24, 2026

The Federal Court of Appeal has upheld a Federal Court decision finding that the drug trademark BYOOVIZ, owned by Samsung Samsung and Biogen, was confusing with the trademark BEOVU, owned by Novartis.

More